Standard of care for advanced biliary cancer should stay as gemcitabine plus a platinum-based agent
Crossref DOI link: https://doi.org/10.1038/nrgastro.2014.104
Published Online: 2014-06-17
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2014-06-17
Article History
First Online: 17 June 2014